Daniel Martinez Selected Research

Daniel Martinez Research Topics

Disease

37	Neoplasms (Cancer) 04/2024 - 11/2007
21	Neuroblastoma 01/2024 - 12/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 01/2019
5	Rhabdoid Tumor (Rhabdoid Tumors) 01/2022 - 07/2011
4	Glioma (Gliomas) 01/2022 - 11/2014
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 01/2021
3	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2020
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022 - 06/2009
3	Brain Neoplasms (Brain Tumor) 01/2022 - 02/2020
2	Pneumonia (Pneumonitis) 01/2023 - 01/2023
2	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 03/2022 - 01/2016
2	Infections 01/2022 - 03/2016
2	COVID-19 01/2022 - 04/2021
2	Heart Failure 11/2021 - 06/2011
2	Glioblastoma (Glioblastoma Multiforme) 02/2021 - 09/2013
2	Inflammation (Inflammations) 01/2018 - 08/2014
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2015 - 04/2010
2	Breast Neoplasms (Breast Cancer) 05/2015 - 11/2007
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 06/2011 - 08/2010
1	Cytokine Release Syndrome 04/2024
1	Hepatoblastoma 01/2024
1	Adrenocortical Carcinoma 12/2023
1	Pheochromocytoma 12/2023
1	Paraganglioma (Paragangliomas) 12/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2023
1	Fanconi Syndrome (Syndrome, Fanconi) 03/2022
1	Acidosis 03/2022
1	Proteinuria 03/2022
1	Glycosuria 03/2022
1	Medulloblastoma 01/2022
1	Chondrosarcoma 01/2022

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2012
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2004
8	RNA (Ribonucleic Acid)IBA 12/2022 - 11/2017
7	Immunoconjugates (Immunoconjugate)IBA 12/2023 - 11/2017
4	3-Iodobenzylguanidine (Iobenguane)IBA 01/2024 - 01/2012
4	GlypicansIBA 12/2022 - 10/2011
4	Oncogene Proteins (Oncogene Protein)IBA 12/2022 - 11/2017
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
4	Cyclin D1IBA 01/2020 - 11/2015
3	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2024 - 01/2012
3	Membrane Proteins (Integral Membrane Proteins)IBA 12/2023 - 01/2020
3	CytokinesIBA 12/2022 - 04/2018
3	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 12/2022 - 01/2021
3	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2016
3	LigandsIBA 01/2022 - 08/2021
3	AntigensIBA 01/2022 - 01/2016
3	Histones (Histone)IBA 10/2021 - 09/2013
3	Transcription Factors (Transcription Factor)IBA 11/2015 - 06/2009
2	RadiopharmaceuticalsIBA 11/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2013
2	B7-H1 AntigenIBA 02/2021 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2016
2	ChromatinIBA 01/2019 - 01/2019
2	ribociclibIBA 04/2017 - 11/2013
2	Carbon DioxideIBA 06/2011 - 08/2010
1	Caspase 9IBA 04/2024
1	Interleukin-15 (Interleukin 15)IBA 04/2024
1	Interferon Type IIBA 04/2024
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2024
1	Small Interfering RNA (siRNA)IBA 12/2023
1	4-carboxyphenylglyoxalIBA 12/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Myosins (Myosin)IBA 01/2023
1	InterleukinsIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Amikacin (A.M.K)FDA LinkGeneric 01/2023
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	CalreticulinIBA 12/2022
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 12/2022
1	Poly Adenosine Diphosphate RiboseIBA 11/2022
1	PolymersIBA 04/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022
1	ElectrolytesIBA 03/2022
1	Ifosfamide FDA LinkGeneric 03/2022
1	EnzymesIBA 01/2022
1	Activating Transcription Factor 6IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	rovalpituzumab tesirineIBA 01/2022
1	VaccinesIBA 01/2022
1	Single-Chain AntibodiesIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2022
1	Inositol (Myoinositol)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2022
1	meta-((211)At)astatobenzylguanidineIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Proline (L-Proline)FDA Link 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Activating Transcription Factor 4IBA 01/2022

Therapy/Procedure

16	Therapeutics 01/2024 - 06/2009
6	Immunotherapy 12/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 03/2022 - 01/2013
2	Radiotherapy 10/2021 - 09/2017
2	Mechanical Ventilators (Ventilator) 06/2011 - 08/2010
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2022